24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
MD · Diagnostic

Apheresis and Transfusion in Special Groups Thesis Topics for MD Immunohaematology & Blood Transfusion — 47+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 47+ MD Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

47+MD Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 47 titles See a full thesis plan
Apheresis and Transfusion in Special Groups thesis topics

MD Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) — Thesis Title List

47 titles · instant objectives
  1. 001

    Single-donor apheresis platelets versus random donor platelets in thrombocytopenic patients: corrected count increment and reactions

    Apheresis Prospective comparative study Comparative Study
    Objective
  2. 002

    Therapeutic plasma exchange in neurological and haematological disorders: indications, complications and outcome

    Apheresis Prospective observational study Descriptive Study
    Objective
  3. 003

    Outcome of therapeutic plasma exchange in thrombotic thrombocytopenic purpura and Guillain-Barre syndrome

    Apheresis Prospective observational study Prospective Study
    Objective
  4. 004

    Peripheral blood stem cell collection by apheresis: factors affecting CD34+ yield and donor adverse events

    Apheresis Prospective observational study Prospective Study
    Objective
  5. 005

    Red cell exchange in sickle cell disease: indications, efficacy and complications

    Apheresis Prospective observational study Descriptive Study
    Objective
  6. 006

    Transfusion requirements, alloimmunisation and iron overload in transfusion-dependent thalassaemia patients

    Transfusion in Special Groups Hospital-based cross-sectional study Cross-sectional Study
    Objective
  7. 007

    Neonatal transfusion practices and adverse events in a tertiary care NICU

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  8. 008

    Platelet transfusion thresholds and outcomes in patients with haematological malignancies on chemotherapy

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  9. 009

    Blood component usage in cardiac surgery and effect of point-of-care coagulation testing on transfusion

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  10. 010

    Intrauterine transfusion for Rh alloimmunised pregnancies: outcome and complications

    Transfusion in Special Groups Retrospective record-based study Descriptive Study
    Objective
  11. 011

    Platelet refractoriness in multi-transfused patients: prevalence, HLA alloimmunisation and management

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  12. 012

    Adverse events in plateletpheresis donors: prevalence and predictors

    Apheresis Prospective observational study Prospective Study
    Objective
  13. 013

    Pre-donation platelet count and donor weight as predictors of plateletpheresis yield

    Apheresis Prospective observational study Analytical Study
    Objective
  14. 014

    Double-dose plateletpheresis: donor safety and product quality

    Apheresis Prospective observational study Prospective Study
    Objective
  15. 015

    Therapeutic plasma exchange in neuromyelitis optica spectrum disorder and myasthenic crisis: response and complications

    Apheresis Prospective observational study Prospective Study
    Objective
  16. 016

    Therapeutic plasma exchange in acute liver failure: biochemical response and transplant-free survival

    Apheresis Prospective observational study Prospective Study
    Objective
  17. 017

    Albumin versus albumin with plasma as replacement fluid in therapeutic plasma exchange: coagulation changes

    Apheresis Prospective comparative study Comparative Study
    Objective
  18. 018

    Leukapheresis for hyperleucocytosis in acute leukaemia: efficacy and complications

    Apheresis Prospective observational study Descriptive Study
    Objective
  19. 019

    Therapeutic plasma exchange in snake envenomation-associated thrombotic microangiopathy

    Apheresis Prospective observational study Descriptive Study
    Objective
  20. 020

    Iron status of repeat plateletpheresis donors

    Apheresis Cross-sectional study Cross-sectional Study
    Objective
  21. 021

    Satisfaction and return rate of first-time apheresis donors

    Apheresis Cross-sectional questionnaire-based study Cross-sectional Study
    Objective
  22. 022

    Prophylactic oral calcium for citrate-related symptoms during plateletpheresis

    Apheresis Prospective interventional study Interventional Study
    Objective
  23. 023

    Probable sarcopenia and bone health in transfusion-dependent beta thalassaemia

    Transfusion in Special Groups Hospital-based cross-sectional study Cross-sectional Study
    Objective
  24. 024

    Pre-transfusion haemoglobin, chelation adherence and serum ferritin in transfusion-dependent thalassaemia

    Transfusion in Special Groups Prospective observational study Analytical Study
    Objective
  25. 025

    Neonatal exchange transfusion: indications, component use and adverse events

    Transfusion in Special Groups Prospective observational study Descriptive Study
    Objective
  26. 026

    Platelet transfusion thresholds in preterm neonates: practice and bleeding outcomes

    Transfusion in Special Groups Prospective audit Audit
    Objective
  27. 027

    Blood component requirements in living donor liver transplantation

    Transfusion in Special Groups Prospective observational study Descriptive Study
    Objective
  28. 028

    Alloimmunisation and delayed haemolytic reactions in transfused patients with sickle cell disease

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  29. 029

    Red cell transfusion for anaemia of prematurity: practice and outcome

    Transfusion in Special Groups Prospective audit Audit
    Objective
  30. 030

    Alloimmunisation and platelet refractoriness in patients with aplastic anaemia

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  31. 031

    Maximum surgical blood order schedule for obstetric procedures

    Transfusion in Special Groups Retrospective record-based study Quality Improvement Study
    Objective
  32. 032

    Transfusion thresholds and adverse events in paediatric oncology patients

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  33. 033

    Quality of life in children with transfusion-dependent thalassaemia and its association with serum ferritin

    Transfusion in Special Groups Hospital-based cross-sectional study Cross-sectional Study
    Objective
  34. 034

    Effect of an awareness drive on knowledge and willingness for plateletpheresis donation among undergraduate medical students

    Apheresis Pre-post interventional study KAP Study
    Objective
  35. 035

    Red cell transfusion practice before therapeutic leukapheresis in patients with hyperleukocytosis at a tertiary-care centre

    Apheresis Retrospective record-based study Descriptive Study
    Objective
  36. 036

    Platelet count recovery and haematological changes in repeat plateletpheresis donors over the inter-donation interval

    Apheresis Prospective observational study Prospective Study
    Objective
  37. 037

    Predictors of CD34-positive cell yield in autologous peripheral blood stem cell harvest at a tertiary-care centre

    Apheresis Prospective observational study Prospective Study
    Objective
  38. 038

    Frequency of multiple red cell alloantibodies and use of adsorption-elution techniques in multiply transfused HbE-beta-thalassaemia patients

    Transfusion in Special Groups Retrospective record-based study Descriptive Study
    Objective
  39. 039

    Physiological versus time-based delayed cord clamping and need for red cell transfusion in preterm neonates

    Transfusion in Special Groups Prospective comparative study Comparative Study
    Objective
  40. 040

    Red cell and platelet transfusion requirement during induction chemotherapy in adults with acute myeloid leukaemia

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  41. 041

    Therapeutic plasma exchange in patients aged above 60 years: indications, procedure-related complications and clinical response

    Apheresis Prospective observational study Prospective Study
    Objective
  42. 042

    Therapeutic plasma exchange in hypertriglyceridaemia-induced acute pancreatitis: triglyceride reduction and clinical outcome

    Apheresis Prospective observational study Prospective Study
    Objective
  43. 043

    Granulocyte yield and donor adverse events in granulocyte apheresis after steroid or G-CSF mobilisation

    Apheresis Prospective observational study Prospective Study
    Objective
  44. 044

    Risk factors for red cell alloimmunisation in multi-transfused patients with haemoglobinopathies at a tertiary-care centre

    Transfusion in Special Groups Hospital-based cross-sectional study Analytical Study
    Objective
  45. 045

    Preparation, utilisation and wastage of red cell aliquots for neonatal and paediatric transfusion at a hospital-based blood centre

    Transfusion in Special Groups Retrospective record-based study Descriptive Study
    Objective
  46. 046

    Blood component requirement during induction therapy in patients with acute promyelocytic leukaemia

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  47. 047

    Transfusion requirement and red cell alloimmunisation in patients with myelodysplastic syndrome at a tertiary-care hospital

    Transfusion in Special Groups Hospital-based cross-sectional study Cross-sectional Study
    Objective

MD Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) thesis — frequently asked questions

How many MD Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) thesis topics are listed here?

47+ MD Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) thesis topics are listed on this page, organised by subsection of the Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, MD and FCPS Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) candidates?

Yes — these Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) dissertation titles are aligned with NMC, NBE and DNB Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) curricula and are suitable for MD Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups), DNB Immunohaematology & Blood Transfusion (Apheresis and Transfusion in Special Groups) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp